Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients.

den Uil, Manon G; Hut, Hannelotte W; Wagelaar, Kay R; Abdullah-Koolmees, Heshu; Cahn, Wiepke; Wilting, Ingeborg; Deneer, Vera H M

den Uil, Manon G; Hut, Hannelotte W; Wagelaar, Kay R; Abdullah-Koolmees, Heshu; Cahn, Wiepke; Wilting, Ingeborg; Deneer, Vera H M.

Afiliação

den Uil MG; Division Laboratories, Pharmacy and Biomedical Genetics, Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands.
Hut HW; Division Laboratories, Pharmacy and Biomedical Genetics, Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands.
Wagelaar KR; Division Laboratories, Pharmacy and Biomedical Genetics, Clinical Pharmacy, University Medical Centre Utrecht, Utrecht, Netherlands.
Abdullah-Koolmees H; Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, Netherlands.
Cahn W; Pharmacy and Clinical Pharmacology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Wilting I; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
Deneer VHM; Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, Netherlands.

Front Genet ; 14: 1249164, 2023.

Article em En | MEDLINE | ID: mdl-37693320

Palavras-chave

CYP2C19; CYP2D6; pharmacogenetics; phenoconversion; psychiatric drugs; side effects

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Genet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google